SEC Form 4 · accession 0001209191-17-017880
TENET HEALTHCARE CORP · THC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J Cancelmi
Officer — Chief Financial Officer
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070318
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 March Restricted Stock UnitsF1 | — | Mar 1, 2017 | A | 40,373 | A | — | — | Common Stock | 40,373 | 40,373 | D |
| 2017 March Performance Stock Options (Right to Buy)F2 | $18.99 | Mar 1, 2017 | A | 89,976 | A | — | Mar 1, 2027 | Common Stock | 89,976 | 89,976 | D |
Explanation of responses
- F1These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.
- F2These performance-based stock options vest on the third anniversary of the date of grant, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $23.74 per share for any 20 consecutive trading days during the three-year period following the date of grant.